Bellevue Group’s Inspire Medical Systems INSP Stock Holding History

Bellevue Group’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.14M	Sell	99,735 -1,026	-1%	-$71.8K	0.12%	71
2025 Q4	$9.29M	Buy	100,761 +42,113	+72%	+$4.03M	0.18%	65
2025 Q3	$4.35M	Sell	58,648 -17,012	-22%	-$1.72M	0.09%	79
2025 Q2	$9.82M	Sell	75,660 -23,367	-24%	-$3.39M	0.22%	64
2025 Q1	$15.8M	Sell	99,027 -49,451	-33%	-$8.95M	0.35%	58
2024 Q4	$27.5M	Sell	148,478 -46,602	-24%	-$9.05M	0.53%	47
2024 Q3	$41.2M	Buy	195,080 +70,356	+56%	+$12.2M	0.67%	41
2024 Q2	$16.7M	Sell	124,724 -92,970	-43%	-$17.6M	0.27%	81
2024 Q1	$46.8M	Buy	217,694 +2,094	+1%	+$410K	0.71%	43
2023 Q4	$43.9M	Buy	215,600 +145,232	+206%	+$23.5M	0.67%	48
2023 Q3	$14M	Sell	70,368 -286,652	-80%	-$72.3M	0.23%	80
2023 Q2	$116M	Sell	357,020 -20,048	-5%	-$5.73M	1.65%	16
2023 Q1	$88.3M	Sell	377,068 -24,674	-6%	-$6.24M	1.28%	21
2022 Q4	$101M	Sell	401,742 -26	-0%	-$5.54K	1.34%	22
2022 Q3	$71.3M	Sell	401,768 -5,289	-1%	-$1.06M	1.02%	33
2022 Q2	$74.4M	Buy	407,057 +9,551	+2%	+$1.9M	1.05%	29
2022 Q1	$102M	Sell	397,506 -23,274	-6%	-$5.32M	1.18%	27
2021 Q4	$96.8M	Sell	420,780 -278	-0.1%	-$67.9K	1%	32
2021 Q3	$98.1M	Buy	421,058 +47,832	+13%	+$9.98M	1%	34
2021 Q2	$72.1M	Buy	373,226 +53,038	+17%	+$10.5M	0.7%	48
2021 Q1	$66.3M	Buy	320,188 +20,971	+7%	+$4.46M	0.7%	51
2020 Q4	$56.3M	Buy	299,217 +26,234	+10%	+$4.29M	0.64%	48
2020 Q3	$35.2M	Buy	272,983 +28,733	+12%	+$3.17M	0.49%	59
2020 Q2	$21.3M	Buy	244,250 +107,025	+78%	+$8.23M	0.3%	77
2020 Q1	$8.27M	Sell	137,225 -125,992	-48%	-$9.32M	0.16%	92
2019 Q4	$19.5M	Buy	263,217 +19,760	+8%	+$1.27M	0.31%	61
2019 Q3	$14.9M	Buy	243,457 +49,117	+25%	+$3.23M	0.28%	69
2019 Q2	$11.8M	Buy	194,340 +71,235	+58%	+$3.84M	0.2%	77
2019 Q1	$6.99M	Buy	123,105 +30,489	+33%	+$1.65M	0.38%	67
2018 Q4	$3.91M	Buy	92,616 +1,920	+2%	+$81.6K	0.27%	78
2018 Q3	$3.82M	Buy	90,696 +42,743	+89%	+$2.01M	0.24%	81
2018 Q2	$1.71M	Buy	+47,953	New	+$1.55M	0.15%	93